11 September 2017Americas

Allergan and Native American tribe in patent deal

Allergan has transferred its patent rights for a dry eye treatment to a Native American tribe, in a bid to obtain immunity against an inter partes review (IPR).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Native American tribe files brief in patent dispute

20 April 2018 The Saint Regis Mohawk Tribe and Allergan have filed a brief in a dispute over whether tribal sovereign immunity can protect patents from the inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB).

Americas

Allergan deal with tribe could kill off IPR: Bryson

17 October 2017 A US judge has said Allergan’s controversial patent licensing deal with a Native American tribe could spell the end for the inter partes review.

Americas

House of Representatives committee probes Allergan IPR deal

4 October 2017 A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe.

More on this story

Americas

Native American tribe files brief in patent dispute

Americas

Allergan deal with tribe could kill off IPR: Bryson

17 October 2017 A US judge has said Allergan’s controversial patent licensing deal with a Native American tribe could spell the end for the inter partes review.

Americas

House of Representatives committee probes Allergan IPR deal

4 October 2017 A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe.

More on this story

Americas

Native American tribe files brief in patent dispute

Americas

Allergan deal with tribe could kill off IPR: Bryson

17 October 2017 A US judge has said Allergan’s controversial patent licensing deal with a Native American tribe could spell the end for the inter partes review.

Americas

House of Representatives committee probes Allergan IPR deal

4 October 2017 A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe.